Filing Flows › Comparisons › QTRX vs HBIO
Quanterix vs Harvard Bioscience: QTRX and HBIO compared
Quanterix is the larger company: $32.9M of revenue in its latest quarter (Q2 2026) against $22.7M for Harvard Bioscience (Q2 2026). Quanterix is growing faster (+34% against +11% a year earlier). Harvard Bioscience is more profitable, with an operating margin of -4.3% against -150.2%.
Where the money goes: QTRX and HBIO
Quanterix (QTRX) · Q2 2026
Quanterix, Q2 2026: revenue $32.9M (+34% year over year), operating margin -150.2%, net loss $48.9M, operating cash flow −$5.1M. The chart follows the revenue to costs, profit and cash.
Harvard Bioscience (HBIO) · Q2 2026
Harvard Bioscience, Q2 2026: revenue $22.7M (+11% year over year), operating margin -4.3%, net loss $2.9M, operating cash flow $325K. The chart follows the revenue to costs, profit and cash.
| Quanterix (QTRX) | Harvard Bioscience (HBIO) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $32.9M | $22.7M |
| Revenue growth, Y/Y | +34% | +11% |
| Operating margin | -150.2% | -4.3% |
| Net earnings | −$48.9M | −$2.9M |
| Net margin | -148.7% | -12.8% |
| Operating cash flow | −$5.1M | $325K |
| Market value | $147M | — |
| Analysts’ mean target | $3.17 | — |
Where the revenue comes from
Quanterix
- Product revenue: $23.4M (71%)
- Spatial biology: $9.3M (28%)
Harvard Bioscience
- Instruments, Equipment, Software, and Accessories: $20.3M (89%)
- Service, Maintenance, and Warranty Contracts: $2.4M (11%)
Questions
Which is bigger, Quanterix or Harvard Bioscience?
Quanterix is the larger company: $32.9M of revenue in its latest quarter (Q2 2026) against $22.7M for Harvard Bioscience (Q2 2026).
Is Quanterix or Harvard Bioscience growing faster?
Quanterix is growing faster (+34% against +11% a year earlier).
Which is more profitable, Quanterix or Harvard Bioscience?
Harvard Bioscience is more profitable, with an operating margin of -4.3% against -150.2%.
More: Quanterix earnings · how Quanterix makes money · Harvard Bioscience earnings · how Harvard Bioscience makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 10, 2026; 10-Q filed Aug 11, 2026). Fiscal quarters can end on different dates. Not investment advice.